Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Abstract: Described is a mobile point-of sale cart for use in a retail store. The cart has four legs and three platforms coupled to the legs. Each of the three platforms is at a different height above the ground. The legs have wheels for easy movement from one place to another, and the legs are telescoping so the cart can be easily stored. The cart holds the equipment needed for a retail store employee to checkout customers and perform other common tasks. The cart has multiple bins to hold a handheld scanner, a debit card reader, and a portable printer. The cart has a bagging station coupled to the top platform, and a shopping bag support surface coupled to the second platform. The cart can be moved about the store to easily ring up purchases, and can be stored when not in use.

Abstract: The present invention provides organic compounds which are capable of releasing carbon monoxide under physiological conditions or pH trigger, and to the use of such compounds for conditioning a cell, tissue or organ, for example, to protect against ischaemic injury during a transplant event.

Abstract: Described is a mobile point-of sale cart for use in a retail store. The cart has four legs and three platforms coupled to the legs. Each of the three platforms is at a different height above the ground. The legs have wheels for easy movement from one place to another, and the legs are telescoping so the cart can be easily stored. The cart holds the equipment needed for a retail store employee to checkout customers and perform other common tasks. The cart has multiple bins to hold a handheld scanner, a debit card reader, and a portable printer. The cart has a bagging station coupled to the top platform, and a shopping bag support surface coupled to the second platform. The cart can be moved about the store to easily ring up purchases, and can be stored when not in use.

Abstract: The invention relates to sphingoglycolipid analogs and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.

Abstract: The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.

Abstract: This invention relates to sphingoglycolipid analogs, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.

Abstract: The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.

Abstract: The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.

Abstract: A thin agent installed within a guest virtual machine (GVM) enables a service application to monitor events within the GVM and to perform certain system functions within the GVM. The thin agent maintains a distinct set of rules for selectively reporting system events to each different service application connected to the thin agent. A multiplexer executing within a virtualization software is configured to facilitate communication between a plurality of thin agents and a plurality of service applications. A services manager facilitates communication between new service applications and the thin agents. Each service application is able to advantageously add new functions to production GVMs without interrupting proper operation of the GVMs.

Abstract: This invention relates to sphingoglycolipid analogues, compositions comprising these compounds, processes for preparing the compounds, and methods of treating or preventing diseases or conditions using the compounds, such as diseases or conditions relating to infection, atopic disorders, autoimmune disease, diabetes or cancer.

Abstract: Computer implemented methods, system and apparatus for managing execution of a running-page in a virtual machine include associating an execution trace code with the running page by a security virtual machine. The execution trace code generates a notification upon initiation of the execution of the running page by the virtual machine. The notification is received by the security virtual machine running independent of the virtual machine executing the running-page. The running page associated with the execution trace code is validated by the security virtual machine as authorized for execution. An exception is generated if the running-page is not authorized for execution. The generated exception is to prevent the execution of the running page in the virtual machine.

Abstract: A method and a system scan a virtual machine (VM). The method stores a first copy of a scan token associated with a first scan operation within a VM and stores a second copy of the scan token in a database accessible by a management module. Upon restarting of the VM, a scan token in the restarted VM is compared with a scan token associated with the restarted VM in the database. The scan token in the restarted VM is current when the scan token in the restarted VM matches the scan token in the database. A first scan operation is resumed on the restarted VM when it is determined that the scan token in the restarted VM is current, and a new first scan operation of the restarted VM is initiated when it is determined that the scan token in the restarted VM is not current.

Abstract: A method and a system scan a virtual machine (VM). The method stores a first copy of a scan token associated with a first scan operation within a VM and stores a second copy of the scan token in a database accessible by a management module. Upon restarting of the VM, a scan token in the restarted VM is compared with a scan token associated with the restarted VM in the database. The scan token in the restarted VM is current when the scan token in the restarted VM matches the scan token in the database. A first scan operation is resumed on the restarted VM when it is determined that the scan token in the restarted VM is current, and a new first scan operation of the restarted VM is initiated when it is determined that the scan token in the restarted VM is not current.

Abstract: A system is provided to facilitate on-demand data scan operation in a guest virtual machine. During operation, the system generates an on-demand scan request at a scanning virtual machine, wherein the request specifies a scope for the on-demand scan. The system communicates the on-demand scan request to the guest virtual machine and receives data from the guest virtual machine in response to the request. The system identifies the data as candidate for on-demand scanning and scans the data in furtherance of a security or data integrity objective.

Abstract: Computer implemented methods, system and apparatus for managing execution of a running-page in a virtual machine include associating an execution trace code with the running page by a security virtual machine. The execution trace code generates a notification upon initiation of the execution of the running page by the virtual machine. The notification is received by the security virtual machine running independent of the virtual machine executing the running-page. The running page associated with the execution trace code is validated by the security virtual machine as authorized for execution. An exception is generated if the running-page is not authorized for execution. The generated exception is to prevent the execution of the running page in the virtual machine.

Abstract: The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosaccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disorders.

Abstract: The present invention is directed to synthetic molecules having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity, for use in the treatment and prevention of inflammatory or immune cell mediated diseases or disorders.